Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
'Something Very Bad Is Going to Happen' is the Duffer Brothers' first project since 'Stranger Things.' It's also 'wildly insane.' - 2Iran war drives global fertilizer prices up, raising food cost fears
- 3Find the Specialty of Calligraphy: Dominating the Exquisite Art of Penmanship
- 4Gunmen open fire near Israeli consulate in Istanbul in possible ISIS-linked attack
- 5'Yellowstone' made him a fan favorite. His biggest role isn't the one you see.
- Everyone knows F1 is for the girls. I wandered into the Las Vegas desert to find out why.
- Cells have more mini ‘organs’ than researchers thought − unbound by membranes, these rogue organelles challenge biology’s fundamentals
- CPA Canada appoints eight directors as new governance model takes effect
- Iranian strikes on Israel injure 11 and set chemical plant ablaze
- He made a name for himself posting thirst traps on TikTok. Now he's the star of a wildly popular rom-com.
- Hidden Island Cameras Capture Rare Tasmanian Species for the First Time Ever
- The 10 Most Significant Games in History
- ‘Extraordinary’ Iron Age war trumpet uncovered in England
- The Most Compelling Books of the 10 years
